Acceleron Pharma Inc. , a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today announced the pricing of a public offering of 2,400,000 shares of common stock at a public offering price of $50.00 per share, before underwriting discounts.
Business For Sale in Boston News Snippet brought to you by: BizLocal.com
BizLocal provides a Business For Sale Market Place and more.
A web-property of Inspetta LLC, providing innovative web, software and marketing services to business.
Call 800-785-2925 for more information.